Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    "Penile Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
"Penile Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)
Condition: Locally-advanced or Metastatic Penile Neoplasms
Intervention: Drug: Vinflunine
2 Unknown  Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis
Conditions: Penile Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: Dacomitinib
3 Not yet recruiting HOUSTON - Incidence of Oropharyngeal, Anal and Penile Cancer in Men With Antibodies to Human Papillomavirus (HPV)
Conditions: Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs
Interventions: Procedure: Oropharyngeal Cancer Screening;   Procedure: Ultrasound Scans;   Procedure: Anal Cancer Screening;   Procedure: High-Resolution Anoscopy (HRA);   Procedure: Penile Cancer Screening
4 Recruiting E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Biological: E7 TCR cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
5 Not yet recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
6 Active, not recruiting Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis
Conditions: Penile Cancer;   Squamous Carcinoma
Intervention: Drug: Chemotherapie TIP
7 Not yet recruiting International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Condition: Squamous Cell Carcinoma of the Penis, Usual Type
Interventions: Procedure: ILND - Inguinal Lymph Node Dissection;   Drug: Paclitaxel;   Drug: Ifosfamide;   Drug: Cisplatin;   Radiation: Intensity modulated radiation treatment (IMRT);   Procedure: Prophylactic PLND - pelvic lymph node dissection
8 Completed T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Conditions: Vaginal Cancer;   Cervical Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: E6 TCR;   Drug: Aldesleukin
9 Recruiting Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]
Condition: Squamous Cell Carcinoma of the Penis
Intervention: Procedure: MRI-PET
10 Withdrawn Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
Condition: Squamous Cell Carcinoma of the Penis
Interventions: Drug: Cetuximab;   Drug: TIP
11 Recruiting Cancer Research Repository for Individuals With Cancer Diagnosis and High Risk Individuals.
Conditions: Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma
Intervention:
12 Completed Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Oropharyngeal Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer
Interventions: Drug: Fludarabine;   Drug: Cycolphosphamide;   Biological: Young TIL;   Drug: Aldesleukin
13 Completed
Has Results
Cancer in Patients With Gabapentin (GPRD)
Conditions: Pain, Neuropathic;   Epilepsy;   Renal Pelvis Cancer;   Pancreatic Cancer;   Breast Cancer;   Nervous System Cancer;   Chronic Pancreatitis;   Stomach Cancer;   Renal Cell Carcinoma;   Diabetes;   Bladder Cancer;   Bone and Joint Cancer;   Penis Cancer;   Anal Cancer;   Cancer;   Renal Cancer
Intervention: Drug: Gabapentin prescriptions
14 Active, not recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Conditions: Anal Cancer;   Nonneoplastic Condition;   Penile Cancer;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Other: laboratory biomarker analysis
15 Active, not recruiting Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
Conditions: Penile Cancer;   Erectile Dysfunction;   Radical Prostatectomy
Interventions: Drug: Placebo QHS and sildenafil and questionnaires;   Drug: Sildenafil and questionnaire;   Drug: Trimix combination (Papavarine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mmL) and questionnaires
16 Completed
Has Results
Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
Condition: Penile Cancer
Interventions: Drug: Ifosfamide;   Drug: Paclitaxel (Taxol);   Drug: Cisplatin
17 Completed Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
Condition: Penile Cancer
Interventions: Drug: cisplatin;   Drug: irinotecan hydrochloride;   Procedure: neoadjuvant therapy
18 Terminated S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
Condition: Penile Cancer
Intervention: Drug: docetaxel
19 Completed Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
Conditions: Anal Cancer;   Cervical Cancer;   Esophageal Cancer;   Head and Neck Cancer;   Penile Cancer;   Vulvar Cancer
Interventions: Biological: human papillomavirus 16 E7 peptide;   Biological: synthetic human papillomavirus 16 E6 peptide
20 Completed Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Conditions: Cervical Cancer;   Esophageal Cancer;   Head and Neck Cancer;   Lung Cancer;   Non-melanomatous Skin Cancer;   Penile Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: isotretinoin

Indicates status has not been verified in more than two years